Videos

Delivering on Innovation: CPL Supports Optinose with Reliable Manufacturing for XHANCE® and Future Expansion

CPL is proud to be the trusted commercial manufacturing partner for Optinose’s innovative XHANCE^® therapy, a combination of fluticasone and an advanced delivery device for the treatment of nasal polyps. Michael Berkey

Vice President, Technical Operations, OptiNose, discusses how, for over five years, CPL has ensured a consistent supply of high-quality product to support patients with chronic nasal inflammation. With a shared commitment to quality, reliability, and patient outcomes, CPL is positioned as a critical partner in Optinose’s continued success.

Partner with CPL

Have questions about this topic or want to discuss your project? Our team is here to help.

First Name

Last Name

Company

Job Title

Phone

Product Type

Development Stage

Service of Interest

Product / Formulation Development Product Testing / Skin Lab Tech Transfer Clinical Manufacturing Commercial Manufacturing/Packaging

Message

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and our commitment to protecting and respecting your privacy, please review our Privacy Policy.

By clicking submit below, you consent to allow CPL to store and process the personal information submitted above.

Required Fields

See all Expert Resources